Tussidex

Quick links to important sections

Tussidex

Treatment option: Cough

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tussidex

What Type of Medicine Is Tussidex and What Does It Contain?

Tussidex is a medicinal preparation whose defining active ingredient is Dextromethorphan Hydrobromide, classifying the drug primarily as a non-opioid antitussive agent (cough suppressant). This compound is a synthetic chemical entity that is structurally related to levorphanol, distinguishing it chemically from narcotic cough medicines. The inclusion of Dextromethorphan Hydrobromide as the primary substance is intended for action on the cough reflex. Tussidex is typically available Over-the-Counter (OTC), reflecting its availability for general consumer access.

How Does Tussidex Function and What Is Its General Purpose?

The general purpose of Tussidex is to provide symptomatic relief by reducing the severity and frequency of an irritating, dry cough, commonly experienced during a typical respiratory tract infection. Its action is central, influencing the neural signals in the brain rather than locally affecting the throat or lungs. The Dextromethorphan component acts on the medullary cough center, effectively increasing the cough threshold and dampening the physical impulse to cough. This mechanism is designed to stabilize the cough reflex and manage the urge to cough.

Available Forms and Preparation Identity

Tussidex is manufactured for oral administration in various dosage forms to facilitate patient intake, including liquid preparations like syrup or oral solution, and solid formats such as capsules or soft capsules. The consistent identity across all preparations is maintained by the presence of Dextromethorphan Hydrobromide as the defining therapeutic substance, whether delivered in an aqueous base or a solid matrix.

Regulatory References

  1. Over-the-Counter (OTC)

What side effects are possible with Tussidex?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety characteristics of Dextromethorphan Hydrobromide (Tussidex), strictly based on government regulatory documentation, such as FDA Prescribing Information and EMA Summary of Product Characteristics (SmPC).

Adverse Reaction Scope

The official safety information classifies adverse reactions primarily within the Nervous System Disorders and Gastrointestinal Disorders system-organ classes.

Classification Common Adverse Reactions Serious Safety Concerns
Frequency Dizziness, somnolence (drowsiness), nausea, and vomiting are classified as Common effects. Serious allergic reactions are documented as Rare. Potential for abuse is classified as Frequency Not Known (post-marketing).
System Focus Central Nervous System and Gastrointestinal Tract. Serious psychiatric and cardiovascular consequences related to drug interaction.

Regulatory Safety Considerations

The safety profile includes explicit limitations and restrictions on use. The medication is absolutely contraindicated for use in patients who are currently taking or have recently (within 14 days) discontinued a Monoamine Oxidase Inhibitor (MAOI) due to the risk of Serotonin Syndrome—a potentially serious reaction.

Population-Specific Notes detail that caution is advised in individuals with hepatic impairment, as the drug’s clearance may be reduced. Furthermore, official labels specify constraints on use in pediatrics, with recommendations often limiting use in children below a specific age. Common adverse effects, such as drowsiness and GI discomfort, are typically reported to appear during the initial phase of treatment, while the potential for dependence is associated with prolonged, supratherapeutic exposure.

Overdose and Emergency Response

Tussidex contains Dextromethorphan, an ingredient whose overdose profile is strictly defined in authoritative regulatory and medical texts due to its potential for serious toxicity.

Documented Overdose Symptoms

Symptoms following an overdose are dose-dependent and affect the neurological, cardiovascular, and muscular systems. Documented presentations include agitation, confusion, ataxia (unsteady gait), nystagmus (involuntary eye movements), tachycardia, and hypertension. Severe symptoms escalate to seizures, respiratory depression, coma, and toxic psychosis.

Critical Risk Factors and Emergency Action

A critical risk is the potential for Serotonin Syndrome, which is exacerbated if the product is co-ingested with other serotonergic medicines (such as MAOIs or SSRIs). The overall severity is classified as ranging from mild effects to life-threatening complications, including rhabdomyolysis (severe muscle breakdown).

When to Seek Immediate Medical Help:

Get medical help or call an emergency number right away. This is a serious overdose that requires immediate professional evaluation and supportive care, even if initial symptoms are mild. Management is supportive and may involve the administration of activated charcoal within the first hour of ingestion. Naloxone may be used to reverse central nervous system and respiratory depression in a clinical setting.

Therapeutic Uses of Tussidex

What Tussidex Treats: Main Uses and Benefits

The primary therapeutic role of Tussidex is to provide focused symptomatic relief by managing the disruptive cough impulse associated with acute illnesses. It is applied in clinical settings where the non-productive cough is a symptom that creates noticeable physiological strain and may cause distress. The medication is commonly used to help manage the temporary relief of cough caused by the common cold, flu, or other minor irritations.

Tussidex is used for managing manifestations of the dry, hacking cough during the acute phases of upper respiratory tract infections. It helps address symptom clusters that include persistent airway irritation and the involuntary urge to cough. This provides supportive relief when these symptoms create noticeable interference with daily stability. The medication is relevant in situations where symptoms lead to temporary functional strain, particularly when nocturnal coughing episodes interfere with daily functioning, such as sleep.

“The primary goal of this supportive medication is to assist with easing the overall symptom load during periods of heightened patient distress from cough.”

By offering short-term symptomatic assistance to dampen the persistent cough impulse, Tussidex may assist with improved comfort and rest during symptomatic periods, and supports patients during difficult episodes.


Quick Fact: Relief for Dry, Irritating Cough Tussidex is commonly used to address coughs that are non-productive, and assists with maintaining functional stability by managing the frequency and intensity of coughing fits.

Regulatory References

  1. NIH MedlinePlus overview on Dextromethorphan

Eligibility and Restrictions for Use

Tussidex, which contains dextromethorphan as its active ingredient, is primarily indicated for the temporary relief of a dry, non-productive cough that is not associated with excessive mucus. It is typically used for acute coughs resulting from the common cold or flu.

Who Can Use Tussidex?

  • Adults and children over the minimum age specified on the product label (often age 4 or 6, depending on the formulation and country).
  • Individuals experiencing an irritating, dry, or ticklish cough.

Who Cannot Use Tussidex (Contraindications)?

Consult a healthcare professional before use if you have certain medical conditions or are taking specific medications. Tussidex is generally contraindicated in cases of:

Contraindication Category Examples/Conditions
Drug Interactions Use of Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping them. Increased risk of Serotonin Syndrome when combined with certain antidepressants (SSRIs, SNRIs).
Respiratory Conditions Chronic cough (e.g., from smoking, asthma, or emphysema), cough that produces a lot of mucus, or a risk of respiratory failure (e.g., severe asthma or COPD).
Other Conditions Known hypersensitivity/allergy to dextromethorphan or other product ingredients, or severe liver impairment.
Special Populations Women who are breastfeeding. Use during pregnancy requires consulting a doctor to weigh potential risks and benefits. Use in children under the minimum age on the label is generally avoided.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Tussidex (Dextromethorphan Hydrobromide) establishes constraints based on the risks of metabolic inhibition and additive pharmacodynamic effects. The most severe restriction is the contraindication against co-administration with Monoamine Oxidase Inhibitors (MAOIs), which requires a mandatory 14-day wash-out period before or after Tussidex administration.

Pharmacokinetic and Exposure Interactions

Mechanism Interacting Substances Outcome Described in Label
CYP2D6 Inhibition Potent CYP2D6 Inhibitors (e.g., Quinidine, Fluoxetine, Paroxetine) Leads to multi-fold higher plasma concentrations and exposure to Dextromethorphan, increasing the risk of toxic effects.
Genetic Variability CYP2D6 Poor Metabolizers Exhibit naturally reduced drug clearance, resulting in significantly higher systemic exposure.

Pharmacodynamic Interactions

Combining Tussidex with other serotonergic agents, such as Selective Serotonin Reuptake Inhibitors (SSRIs) or Tricyclic Antidepressants (TCAs), may result in Serotonin Syndrome due to additive activity. Furthermore, co-administration with Central Nervous System (CNS) Depressants, including alcohol or narcotic analgesics, is officially documented as having an additive effect that increases overall CNS depression.

Mechanism of Action

Tussidex works through the action of its active component, Dextromethorphan, which selectively engages multiple pathways in the central nervous system to influence involuntary reflexes.


Central Cough Reflex Modulation

Dextromethorphan acts within domains involving receptor- or enzyme-mediated signaling located in the brainstem's cough center (medulla). It directly modifies the signaling sequences in this region that regulate the cough reflex, leading to adjustments in the overall excitability of this pathway.


NMDA Receptor Antagonism

The mechanism involves regulating neural signaling by acting as a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptors. Modifying these early molecular steps reduces the functional availability of the signaling mediator, thereby adjusting the basal level of activity within the targeted neural pathways.


Sigma-1 Receptor Pathway Effects

The drug also influences systems where specific transmitters dominate through its role as an agonist at the Sigma-1 receptor. This activity influences the feedback regulation of physiological response pathways and may be relevant in cascades where multiple layers of pathway activation occur.

Dosage and Administration Information

How to Use Tussidex

The general principles for using Tussidex (Dextromethorphan Hydrobromide) focus strictly on administration and dosing.


Administration and Dosing Principles

Instruction Detail
Route of Administration The method of use is the oral route, applying to all marketed forms.
Standard Dosing Regimen For adults and adolescents (12 years), the standard immediate-release dose is typically 10 mg to 20 mg, or alternatively \mathbf30 mg per administration. The total intake must not exceed a maximum of \mathbf120 mg over a 24-hour period.
Frequency Pattern Immediate-release formulations are generally taken every \mathbf4 hours (for 10 mg to 20 mg doses) or every \mathbf6 to 8 hours (for 30 mg doses) on an as-needed basis.

Procedural and Duration Constraints

Administration involves adhering to specific procedural instructions and duration limits:

  • Liquid Forms: Solutions and syrups must be measured precisely using a specially marked dosing device; household spoons should not be used. Liquid preparations should also be shaken well before each use.
  • Extended-Release (ER) Forms: If administering an extended-release tablet or capsule, the dosage form must not be crushed, chewed, or broken before swallowing.
  • Timing: The medicine can generally be administered without regard to the timing of meals.
  • Duration of Use: Use is intended for short-term relief only and should generally not exceed \mathbf7 days.
  • Missed Doses: If a regular dose is missed, it should be skipped if it is almost time for the next scheduled dose; taking a double dose should be avoided.
  • Pediatric Use: Many adult, over-the-counter preparations carry a restriction to "Do not use" in children under \mathbf12 years of age.

Recent Clinical Evidence

Research evidence / Overview of Studies for Tussidex


Evidence for Use in Acute, Non-Productive Cough in Adults

Research has explored Tussidex (Dextromethorphan) as a substance studied for acute cough, such as the kind was observed in conditions associated with the common cold or flu. These investigations primarily took the form of short-term Randomized Controlled Trials (RCTs). In these studies, researchers examined outcomes related to physical discomfort by measuring how cough frequency and severity changed in the hours after a person took the medicine, compared to a placebo.

For adults, the research describes patterns measured during the study period, with some trials reporting measurements of cough frequency that were observed to be lower compared to an inactive pill at specific time points. However, the overall body of evidence data show patterns related to significant variability. Systematic reviews indicate that evidence quality varies across studies, meaning that certainty remains low for a unified, highly consistent result. The results apply only to the populations studied, and long-term effects are not fully established beyond the short, acute phases of illness.


Evidence in Pediatric Populations (Children)

Research examined pediatric populations, mainly focusing on children who were studied for a cough associated with common respiratory tract infections. The research so far indicates a particular challenge in this area. Studies conducted in children often report how symptoms evolved in the observed populations with findings that were mixed and, in many cases, provided minimal or no clear pattern of difference compared to placebo. As a result, the evidence is limited for consistently characterizing the impact of Dextromethorphan on outcomes related to episodic or acute changes in children. The certainty remains low for this age group, and the general consensus in the scientific literature is that data for certain groups remain insufficient.


Long-Term Studies and Follow-Up Data

The research primarily reflects studies that monitored symptom observation over very limited timeframes. Because acute cough is a self-limiting condition, the follow-up durations were limited, usually focusing on measurements taken over a few hours up to a few days. This means that the evidence derived from settings with varying symptom burdens was studied for short-term symptom changes only. There is limited information for long-term outcomes or durability of effect.


What is Still Uncertain About Tussidex Research

A primary uncertainty in the research landscape relates to the heterogeneity of the trials. The evidence quality varies across studies due to differences in study designs and how researchers chose to measure cough. Furthermore, the limited information for long-term outcomes means the research provides context but not individual predictions regarding the effects of extended use. The subgroup findings are uncertain for many groups beyond the general, otherwise healthy adult population.

Key Studies & References

  1. Cough (acute): antimicrobial prescribing - NICE Guideline [NG120]
  2. Dextromethorphan Pediatric Acute Cough Study (CHPA DXM) (Terminated Trial NCT02651116) - ClinicalTrials.gov

Frequently Asked Questions (FAQ)

Common questions about Tussidex (FAQ)


Q: How quickly does Tussidex typically start to work?

A: Official pharmacological data indicates that the active ingredient in Tussidex, Dextromethorphan, generally begins to work quickly. The onset of effect for immediate-release preparations is typically described as occurring within 15 to 30 minutes after administration.

Q: How long do the effects of Tussidex last?

A: The duration of the therapeutic effects depends on the specific product formulation. Immediate-release preparations are generally described as lasting for 4 to 6 hours. Extended-release forms may provide relief for a longer duration, with some lasting 8 to 12 hours.

Q: What kind of side effects are commonly reported with Tussidex?

A: The official safety documentation classifies a few effects as common adverse reactions. These commonly reported effects include conditions such as dizziness, drowsiness (somnolence), nausea, and vomiting.

Q: Is it normal to feel a bit dizzy after taking Tussidex?

A: Yes, dizziness is classified as a common adverse reaction in the official safety documentation for the active ingredient, Dextromethorphan. Drowsiness (somnolence) is a related common effect that may affect alertness.

Q: What are the signs of a possible serious reaction to Tussidex?

A: Official warnings describe the risk of Serotonin Syndrome when the drug is combined with certain other medicines. Signs of a serious reaction can include agitation, confusion, a fast or irregular heartbeat, fever, or severe muscle stiffness. Serious reactions often prompt an immediate call to emergency services or a poison control center for guidance.

Q: Can Tussidex interact with blood pressure medication?

A: Single-ingredient Dextromethorphan is generally not described in official sources as raising blood pressure. However, it is important to check the product label, as some combination cough products may contain other ingredients, such as decongestants, that could potentially affect blood pressure.

Q: Can Tussidex be taken with common pain relievers like paracetamol?

A: Official interaction data generally indicates that there is no significant interaction between Dextromethorphan and the common pain reliever Paracetamol (Acetaminophen). Official documentation states that specific combination products should always be checked for additional ingredients.

Q: Can individuals with diabetes use Tussidex?

A: Individuals with diabetes often check for formulations that are explicitly labeled as sugar-free or designed for diabetic use. The potential concern for this group relates to the inactive ingredients, such as sugar, sometimes used in liquid and syrup forms, rather than the active medicine itself.

Q: What does the ingredient 'codeine' or 'dextromethorphan' do in Tussidex?

A: The active ingredient in Tussidex, Dextromethorphan, is an antitussive (cough suppressant) that works on the cough center in the brain. Official documents classify it as a non-opioid substance, which distinguishes it chemically from related narcotic or codeine-containing cough medicines.

Q: Can Tussidex be taken if I am already taking an antibiotic?

A: Regulatory data for the active ingredient does not generally indicate a significant interaction with common antibiotics such as amoxicillin. As with all medications, information regarding combination products should be reviewed when starting a new medicine.

Q: Does Tussidex contain sugar or artificial sweeteners?

A: The composition depends on the specific product formulation, as both sugar-containing and sugar-free versions exist. Some liquid products are officially labeled as sugar-free, while others may contain sweeteners, which are detailed in the inactive ingredients section of the product label.

Q: Is Tussidex safe for older adults?

A: Official safety information advises caution for older adults, particularly because of potential increases in side effects like dizziness or drowsiness. Caution is also advised in individuals with reduced liver function, which can be more common in older adults, as this may affect drug clearance.

Q: Can Tussidex be taken for a cough that lasts a long time?

A: Official guidelines specify that use is intended only for short-term relief and should generally not be used for more than 7 days. The drug is contraindicated for coughs classified as chronic, such as those caused by smoking or emphysema, and is not indicated for such prolonged use.

Q: Is Tussidex the same as other common cough syrups?

A: Tussidex is a brand name for a medicine containing the active ingredient Dextromethorphan. It is not the same as every other cough syrup, as many common products may contain different active ingredients or be combination products that include additional medicines.

Q: What is the difference between Tussidex and Dextromethorphan?

A: Dextromethorphan is the active pharmaceutical ingredient, which is the generic name of the medicine. Tussidex is a brand name given to the final commercial medicinal product that contains Dextromethorphan as its primary active substance.

Q: Are there any specific foods or drinks to avoid while taking Tussidex?

A: Official labeling specifically warns against using alcohol due to the risk of additive central nervous system depression. The medicine can generally be administered without regard to meals. Some combination products may have warnings about limiting excessive caffeine intake.

Q: Are there any known interactions between Tussidex and caffeine?

A: Single-ingredient Dextromethorphan does not have a documented significant interaction with caffeine. However, if Tussidex is part of a combination product containing a CNS stimulant, official warnings may advise limiting caffeine intake to prevent excessive stimulation.

Q: Do you need to finish the whole bottle of Tussidex for a cough?

A: No. Official guidelines state that Tussidex is intended for short-term use only and should generally not be used for more than 7 days. It is intended to be stopped when the cough subsides, even if the bottle or package is not empty.

Q: Can Tussidex be taken with herbal supplements?

A: Official safety information advises caution when combining Dextromethorphan with herbal supplements, especially those with known effects on the central nervous system (CNS). Supplements such as St. John's Wort are mentioned due to the potential for additive effects or an increased risk of Serotonin Syndrome.

Q: Are there different strengths of Tussidex available?

A: Yes. The active ingredient Dextromethorphan is manufactured in different strengths to support various dosing recommendations, such as immediate-release formulations and extended-release formulations. The specific strength will be listed on the product label.

Q: Do official documents mention Tussidex affecting mood?

A: Official documentation for the active ingredient, Dextromethorphan, used in combination with other medicines, has recognized effects on the central nervous system. These effects have led to its use in treating Major Depressive Disorder in combination products. Isolated use may also cause adverse CNS effects like drowsiness.

Q: Is Tussidex suitable for coughs caused by allergies?

A: The drug is specifically indicated for the temporary relief of a dry, non-productive cough, typically associated with the common cold or flu. It is not explicitly indicated for coughs caused by allergies, which may be managed by an antihistamine, often found in other cough/cold products.

Q: How does Tussidex compare to over-the-counter cough medicines in terms of regulatory classification?

A: Tussidex (Dextromethorphan) is categorized as a non-opioid antitussive (cough suppressant) agent. In many jurisdictions, this classification permits it to be regulated for consumer access and sold as an Over-the-Counter (OTC) medicine.

Q: What are the most common reasons why a doctor might prescribe Tussidex?

A: The primary reason for its use, as described in official documentation, is the temporary relief of cough symptoms. This includes reducing the frequency and severity of an irritating, dry, non-productive cough commonly associated with the common cold or flu.

Q: What is the purpose of the inactive ingredients in Tussidex?

A: Inactive ingredients are components other than the active medicine that serve various pharmaceutical functions. They are included in the formulation to maintain the product’s stability, to help with absorption, or to provide an acceptable flavor or color for liquid forms.

Q: Is Tussidex effective for coughs related to smoking?

A: Official safety information indicates that Dextromethorphan is generally contraindicated for treating chronic coughs, such as those caused by smoking or emphysema, and is not indicated for this purpose. It is typically reserved for acute, temporary coughs.

Q: What should be done if too much Tussidex is taken accidentally?

A: Official recommendations state that contacting emergency services (such as 911) or a Poison Control Center is the required action if an accidental overdose is suspected. The medication should be kept out of the sight and reach of children.

Q: Can Tussidex cause stomach upset?

A: Yes. Gastrointestinal side effects are considered common, with official safety information listing nausea and vomiting as frequently reported effects. These effects often occur during the initial phase of treatment.

Q: Is it normal for Tussidex to have a specific flavor?

A: Yes. Because Tussidex is available in liquid formulations, it often includes flavorings (such as cherry or sarsaparilla) to make the medicine easier to take. The flavor used is a function of the inactive ingredients listed on the product label.

Q: Why do official sources sometimes recommend against Tussidex for certain age groups?

A: Official restrictions in certain age groups, such as children under 12 for many over-the-counter products, are related to safety considerations. These include concerns about potential for accidental overdose and limited evidence of consistent effectiveness in very young children for acute cough.

How should Tussidex be stored and disposed of?

How to Store and Dispose of Tussidex?

The official labeling mandates specific conditions to maintain the stability and safety of Tussidex (Dextromethorphan Hydrobromide).

Storage Requirements

Tussidex must be stored at Controlled Room Temperature, defined as 15 C to 30 C (59 F to 86 F). It is essential to protect the product from freezing and excessive heat, and to store it in the original container with the cap tightly closed to prevent light and moisture exposure. For safety, the product must be kept out of the sight and reach of children.


Disposal Instructions

Unused or expired medication must be disposed of according to local regulations. Official guidelines recommend utilizing drug take-back programs or following specific instructions for mixing with undesirable substances (like coffee grounds) before placing in the household trash. The product must not be flushed down toilets or poured down drains to protect the water supply.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tussidex found in:

A-Z Index: